Skip to main content

Closed

MLYS: Mineralys Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

37thpctl

Volume

0.40×avg

Market Cap

2.25BUSD

P/E Ratio

-12.8TTM

Div Yield

-ann

Mineralys Therapeutics, Inc.

MLYSNASDAQ Global Select·USD·Closed

Mineralys Therapeutics, Inc.

MLYSNASDAQ·USD·Closed

$25.52

−2.56%

$25.52

−$0.67 (2.56%)

52W Range

37thpctl

Volume

0.40×avg

Mkt Cap

2.25BUSD

P/E

-12.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings